4.3.7 - Managing and coping with stress

What coping means

A useful coping strategy changes something that matters: the demand itself, how it is understood, the bodily response, or the resources available to meet it.

Coping efforts are one part of the broader idea of stress management.

A useful first distinction is between managing the stressor and managing the response. If a student reduces workload by negotiating a deadline, they are changing the stressor. If they use breathing exercises, medication, or social support to feel calmer while the stressor remains, they are changing their response. Social support may also change the stressor directly, for example when a colleague shares the workload.

Lazarus and Folkman's coping approach is useful background here because it separates two broad routes:

When the stressor cannot be changed directly, coping may instead target the response.

The named AQA strategies sit in different places. Drug therapy mainly targets biological symptoms. Biofeedback teaches control over physiological arousal. Stress inoculation therapy changes thoughts, skills and behaviour. Social support can be both practical and emotional, depending on what another person provides.

There is also a 2025-specification detail to handle carefully. Older AQA material and many A-level resources discuss benzodiazepines and beta blockers as drug-therapy examples. The updated AQA bullet no longer names these drug classes, so this lesson treats them as useful examples of drug therapy rather than as the only required drug therapies.

AO2 starting point: If an exam item describes a person with racing heart, shaking hands and panic before a speech, a biological stress-management strategy may be relevant. If it describes someone learning to challenge catastrophic thoughts and rehearse coping statements, stress inoculation therapy is more relevant. If it describes someone receiving lifts, comfort or confidence from others, social support is the key route.

Worked choice: what can actually be changed?

Jules has extra shifts, a deadline and a racing mind at bedtime. Negotiating fewer shifts or dividing tasks with a colleague could reduce the demand. A realistic work plan may restore a sense of control. Asking a friend to listen, using relaxation or reappraising one setback as manageable may reduce distress while the demands remain. The function determines the coping category: talking to a colleague to redistribute tasks is problem-focused, while talking for comfort is emotion-focused.

No named therapy is automatically the best answer to an open coping question. Explain how a feasible strategy addresses the person’s situation. Problem-focused and emotion-focused coping can be combined, and their usefulness depends partly on how changeable the stressor is.

Drug therapy

Drug therapy targets biological symptoms of stress and anxiety.

Drug therapy is based on the idea that stress has a biological component. If stress involves high arousal, excessive anxiety, muscle tension, racing heart or sleep disruption, medication may reduce symptoms quickly enough for the person to function. In Psychology exam answers, the strongest route is to explain mechanism, not just to say "drugs calm people down".

Benzodiazepines as one example

GABA reduces neuronal activity. Benzodiazepines increase GABA's inhibitory effect at GABA-A receptors, making neurons less likely to fire. This can reduce anxiety, tension and physiological arousal. For stress management, the key AO1 chain is:

stressor -> anxiety/arousal -> benzodiazepine enhances GABA -> reduced neural excitation -> calmer state

The AO3 balance is important. Benzodiazepines can act quickly and may be useful in short-term crisis situations. However, NICE guidance for generalised anxiety disorder restricts benzodiazepines to short-term use during crises. Tolerance and dependence limit their value for continuing stress. Side effects such as drowsiness, dizziness and memory problems also limit everyday use.

Beta blockers as another example

Beta blockers such as propranolol are sometimes used for the physical symptoms of anxiety, such as a rapid heartbeat, palpitations and tremor. They can be relevant to physical symptoms in situations such as performance anxiety. This does not establish that they are the best approach for every person, and evidence for treating an anxiety disorder is a different question from reducing a physical symptom. They do not directly remove the person's worries or the source of stress.

The AO1 chain is:

stressor -> sympathetic arousal -> adrenaline/noradrenaline act on the heart -> beta blocker reduces receptor activation -> lower heart-rate symptoms and trembling

AO3: evaluating drug therapy

One strength is speed. Drug therapy may reduce severe symptoms quickly, which can be valuable when a person needs immediate relief or when stress symptoms stop them engaging in psychological therapy. Drug treatment is also relatively easy to standardise and test in controlled trials compared with informal coping strategies.

A limitation is symptom focus. Drug therapy can reduce arousal but may leave the stressor, appraisals and coping skills unchanged. A beta blocker may help a musician's trembling hands before one performance, but it does not teach them how to appraise future performances more realistically. This makes drug therapy potentially reductionist if stress is treated only as a biological problem.

There are also ethical and practical issues. Medication can have side effects, contraindications and dependence risks, so real treatment decisions require medical assessment. In AQA answers, avoid writing as if a student, employer or friend should simply "take drugs" to manage stress.

Stress inoculation therapy

Stress inoculation therapy builds coping skills before they are needed under greater pressure.

SIT is associated with Donald Meichenbaum's cognitive-behavioural work. The name "inoculation" is an analogy: the person is exposed to manageable versions of stress and develops coping resources before facing more intense stressors. It is not a biological vaccine. It is psychological preparation.

Meichenbaum and Deffenbacher (1988) described three overlapping phases.

Phase 1: conceptualisation

In the conceptualisation phase, therapist and client build a collaborative understanding of the stress problem. The client learns how thoughts, emotions, physiological arousal and behaviour interact. They may identify unhelpful self-statements such as "I will definitely fail" or "I cannot cope".

The goal is not just insight. The person starts to reconceptualise the stressor as something manageable with skills, rather than as an overwhelming threat.

Phase 2: skills acquisition and rehearsal

In the skills phase, the person learns a coping toolkit. This may include:

• relaxation or breathing strategies for physiological arousal
• cognitive restructuring to challenge catastrophic thoughts
• self-instruction, such as "I can take this one step at a time"
• problem-solving and planning
• assertiveness or communication skills
• using social support appropriately

These skills are rehearsed so they are available when stress rises. This is a major difference from simply giving advice: SIT trains the person to practise coping.

Phase 3: application and follow-through

In the application phase, the person applies the skills to realistic stressors. This may involve imagery, role play, graded exposure, homework tasks or real-life practice. Follow-through includes reviewing what worked, preventing relapse and adapting skills for future stressors.

Worked application of the phases

A trainee predicts, “If I hesitate once, the whole interview is ruined.” In conceptualisation, the therapist helps identify the link between that prediction, arousal and avoidance of practice. Skills acquisition could involve evaluating the prediction, practising a realistic coping statement and planning answers. Application then uses short mock interviews followed by more demanding practice, with review afterwards. Transfer means using the skills in the next unfamiliar interview, rather than only feeling calmer in the therapist’s room.

AO3: evaluating SIT

One strength is that SIT can build long-term self-efficacy. Instead of only reducing symptoms, it teaches the person how to understand, predict and manage stress. This gives it practical value for recurring stressors such as exams, medical procedures, public speaking or high-pressure work.

There is research support. Saunders et al. (1996) conducted a meta-analysis of 37 studies, with 70 hypothesis tests and 1,837 participants. They found that SIT was effective for reducing performance anxiety and state anxiety and for improving performance under stress. This supports SIT as more than a single small-study effect.

However, SIT is not effortless. It takes time, motivation and access to a trained practitioner. It may be less suitable when the stressor is immediate, severe or uncontrollable, or when someone has limited opportunity to rehearse skills. There is also variation between SIT programmes, so effectiveness can depend on therapist skill, treatment fidelity and whether the training matches the person's stressor.

Biofeedback

Biofeedback makes bodily activity visible so that a person can practise self-regulation.

Biofeedback starts from a simple problem: people often cannot directly see their stress response. They may know they feel tense, but they cannot easily monitor muscle tension, heart-rate variability, skin conductance or breathing pattern. Biofeedback equipment turns these internal changes into visible or audible signals.